The contribution of adipose tissue and adipokines to inflammation in joint diseases

E Toussirot, G Streit, D Wendling - Current medicinal chemistry, 2007 - ingentaconnect.com
Adipokines are proteins produced by white adipose tissue, which is an active secretory organ.
Regulation of immune and inflammatory responses is among the multiple physiological …

Physical activity in patients with rheumatoid arthritis

…, N Tordi, C Prati, C Demougeot, F Mougin, D Wendling - Joint bone spine, 2016 - Elsevier
Introduction Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disease
and is associated with an excess risk of cardiovascular disease. For the general population…

Microvascular endothelial dysfunction in rheumatoid arthritis

…, P Totoson, C Prati, C Marie, D Wendling… - Nature Reviews …, 2018 - nature.com
The systemic autoimmune disease rheumatoid arthritis (RA) is characterized by increased
cardiovascular mortality and morbidity and is an independent cardiovascular risk factor. …

ASAS/EULAR recommendations for the management of ankylosing spondylitis

…, RD Sturrock, S van der Linden, D Wendling… - Annals of the …, 2006 - ard.bmj.com
Objective: To develop evidence based recommendations for the management of ankylosing
spondylitis (AS) as a combined effort of the ‘ASsessment in AS’ international working group …

Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.

D Wendling, E Racadot, J Wijdenes - The Journal of rheumatology, 1993 - europepmc.org
Interleukin 6 (IL-6) appears to be a potential mediator of inflammation that may contribute to
the pathogenesis of joint inflammation in RA. Anti-IL-6 monoclonal antibodies (Mab) may …

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

…, C Michelet, J Morel, X Puéchal, D Wendling… - Annals of the …, 2011 - ard.bmj.com
Background Anti-tumour necrosis factor (TNF) therapy may be associated with opportunistic
infections (OIs). Objective To describe the spectrum of non-tuberculosis OIs associated with …

The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients

…, A Saraux, JM Treluyer, D van Der Heijde, D Wendling - Joint bone spine, 2011 - Elsevier
OBJECTIVES: The French Society of Rheumatology has initiated a large national multicenter,
longitudinal, prospective follow-up of patients presenting with early inflammatory back pain …

Non–TNF-targeted biologic vs a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical …

…, A Perdriger, S Lassoued, JM Berthelot, D Wendling… - Jama, 2016 - jamanetwork.com
Importance One-third of patients with rheumatoid arthritis show inadequate response to tumor
necrosis factor α (TNF-α) inhibitors; little guidance on choosing the next treatment exists. …

Rheumatoid factor and disease activity are independent predictors of lymphoma in primary Sjögren's syndrome

…, B Bienvenu, C Marcelli, D Wendling… - Arthritis & …, 2016 - Wiley Online Library
Objective To define parameters predictive of lymphoma development in patients with primary
Sjögren's syndrome (SS). Methods A multicenter case–control survey was performed to …

Effect of tocilizumab on disease activity in patients with active polymyalgia rheumatica receiving glucocorticoid therapy: a randomized clinical trial

…, E Dernis, C Richez, ME Truchetet, D Wendling… - Jama, 2022 - jamanetwork.com
Importance Few treatments are available for patients with glucocorticoid-dependent
polymyalgia rheumatica. IL-6 antagonists may reduce disease activity in patients with active …